Showing 91-100 of 354 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening | Jaeb Center for Health Research | Adam Glassman | Improving Lives | 01-February-2021 to 31-August-2026 | $750,000.00 |
| Studies of Promising Functional Endpoints in Eyes of Patients with Diabetes (Protocols AR and AS ) | Jaeb Center for Health Research | Adam Glassman | Improving Lives | 01-May-2026 to 30-April-2030 | $1,035,583.00 |
| Towards FDA approval of Autonomous AI for diabetic retinopathy screening in youth | Johns Hopkins University | Risa Wolf | Improving Lives | 01-January-2023 to 31-December-2026 | $637,547.20 |
| REGULATORY ROLE OF CADM1 DURING AUTOIMMUNE DIABETES | Johns Hopkins University | Matthew Poy | Cures | 01-December-2024 to 30-November-2027 | $900,000.00 |
| Harnessing Real-World Data to Advance Cardiorenal Therapies in Type 1 Diabetes | Johns Hopkins University | Jung-Im Shin | Improving Lives | 01-July-2026 to 30-June-2028 | $599,916.46 |
| Exploring Immunologic Mechanisms of Indirect (Encapsulated) Islet Graft Rejection | Johns Hopkins University | Joshua Doloff | Cures | 01-November-2025 to 31-October-2028 | $1,125,000.00 |
| A Novel Bifunctional Biologic for Type 1 Diabetes | Johns Hopkins University | Giorgio Raimondi | Cures | 01-February-2025 to 31-January-2028 | $995,376.00 |
| Targeting RNLS for Type 1 Diabetes Therapy | Joslin Diabetes Center Inc. | Peng Yi | Cures | 01-June-2025 to 31-May-2028 | $1,349,997.00 |
| Harnessing insulin signaling in β-cells to counter type 1 diabetes | Joslin Diabetes Center Inc. | Namrata Shukla | Cures | 01-March-2024 to 28-February-2027 | $216,326.98 |
| Validation of a new approach for cardiovascular disease risk stratification and therapeutic targeting in T1D | Joslin Diabetes Center Inc. | Myra Lipes | Improving Lives | 01-September-2023 to 30-June-2027 | $1,341,376.33 |